By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
AcelRx (ACRX) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/1/2017 2:09:36 PM
AcelRx (ACRX) To Hold A Conference Call And Webcast On Tuesday, August 1st To Discuss ZALVISO Phase III Top-Line Data And Quarterly Financial Results 8/1/2017 2:00:33 PM
AcelRx (ACRX) Succeeds in ZALVISO Phase 3 IAP312 Study on Device Functionality 8/1/2017 8:19:47 AM
AcelRx (ACRX) To Hold Second Quarter 2017 Financial Results Conference Call And Webcast On Wednesday, August 2nd 7/25/2017 11:15:02 AM
AcelRx (ACRX) Appoints Raffi Asadorian As Chief Financial Officer 7/19/2017 6:50:56 AM
AcelRx (ACRX) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/9/2017 10:42:32 AM
AcelRx (ACRX) To Hold First Quarter 2017 Financial Results Conference Call And Webcast On Monday, May 8th, 2017 4/26/2017 10:45:29 AM
AcelRx (ACRX) Reports Publication Of Manuscripts Analyzing IV, Transdermal And Sublingual Patient-Controlled Analgesia Systems 4/13/2017 10:28:28 AM
AcelRx (ACRX) Release: EMA Begins Evaluation Of Marketing Application For Sublingual Sufentanil 30 Mcg Tablet (Arx-04) For Moderate-To-Severe Acute Pain 3/28/2017 6:57:25 AM
AcelRx (ACRX) Reports Fourth Quarter and Year End 2016 Financial Results 3/3/2017 9:45:01 AM
12345678910...
//-->